Rkl Wealth Management LLC Edwards Lifesciences Corp Transaction History

Rkl Wealth Management LLC

$1.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$86.5 - $128.27 $2.05 Million - $3.04 Million	-23,701 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$101.96 - $128.34 $6,729 - $8,470	-66 Reduced 0.28%	23,701 $2.79 Million
Q4 2021 Feb 08, 2022	SELL	$106.37 - $130.68 $1,489 - $1,829	-14 Reduced 0.06%	23,767 $3.08 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $5,454 - $6,505	-53 Reduced 0.22%	23,781 $2.69 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $18,612 - $23,256	-222 Reduced 0.92%	23,834 $2.47 Million
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $113,377 - $130,655	-1,441 Reduced 5.65%	24,056 $2.01 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $67,460 - $85,847	-941 Reduced 3.56%	25,497 $2.33 Million
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $8,331 - $10,842	-124 Reduced 0.47%	26,438 $2.11 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $1.04 Million - $1.38 Million	17,994 Added 210.01%	26,562 $1.84 Million
Q1 2020 Apr 28, 2020	SELL	$52.41 - $81.0 $36,424 - $56,295	-695 Reduced 7.5%	8,568 $1.62 Million
Q4 2019 Feb 04, 2020	SELL	$71.7 - $82.09 $45,601 - $52,209	-636 Reduced 6.42%	9,263 $2.16 Million
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $28,743 - $35,225	-467 Reduced 4.51%	9,899 $2.17 Million
Q2 2019 Aug 02, 2019	SELL	$55.74 - $64.41 $18,895 - $21,834	-339 Reduced 3.17%	10,366 $1.91 Million
Q1 2019 Apr 26, 2019	SELL	$47.89 - $64.05 $20,544 - $27,477	-429 Reduced 3.85%	10,705 $2.05 Million
Q4 2018 Feb 08, 2019	SELL	$46.41 - $56.94 $9,096 - $11,160	-196 Reduced 1.73%	11,134 $1.71 Million
Q3 2018 Nov 07, 2018	BUY	$45.7 - $58.03 $639 - $812	14 Added 0.12%	11,330 $1.96 Million
Q2 2018 Aug 03, 2018	SELL	$42.45 - $51.3 $849 - $1,026	-20 Reduced 0.18%	11,316 $1.65 Million
Q1 2018 Apr 26, 2018	BUY	$37.19 - $47.45 $23,987 - $30,605	645 Added 6.03%	11,336 $1.58 Million
Q4 2017 Feb 02, 2018	BUY	$33.79 - $39.39 $26,626 - $31,039	788 Added 7.96%	10,691 $1.2 Million
Q3 2017 Dec 14, 2017	BUY	$36.29 - $38.83 $359,379 - $384,533	9,903 New	9,903 $1.09 Million
Q3 2017 Nov 07, 2017	SELL	$36.29 - $38.83 $304,400 - $325,706	-8,388 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	8,388	8,388 $991,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.64 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.78 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.34 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.95 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$1 Billion
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rkl Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rkl Wealth Management LLC with notifications on news.

Account